AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lexaria Bioscience Corp. Director's Dealing 2015

Oct 17, 2015

34983_dirs_2015-10-16_0ecb0817-0081-4de3-a761-12ab9e7a72a6.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20

Reporting Person: BUNKA CHRISTOPHER (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-15	Common Shares	P	3000	$0.185	Acquired	5821196	Direct
2015-10-15	Common Shares	P	21200	$0.1834	Acquired	5842396	Direct
2015-10-15	Common Shares	P	5000	$0.1825	Acquired	5847396	Direct
2015-10-15	Common Shares	P	11000	$0.18	Acquired	5858396	Direct
2015-10-15	Common Shares	P	2000	$0.1835	Acquired	5860396	Direct
2015-10-15	Common Shares	P	5000	$0.184	Acquired	5865396	Direct
2015-10-15	Common Shares	P	300	$0.183	Acquired	5865696	Direct
2015-10-16	Common Shares	P	6500	$0.19	Acquired	5872196	Direct
2015-10-16	Common Shares	P	20000	$0.185	Acquired	5892196	Direct
2015-10-16	Common Shares	P	5000	$0.1849	Acquired	5897196	Direct
2015-10-16	Common Shares	P	2500	$0.2	Acquired	5899696	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	4488958	Indirect
Common Shares	5818196	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.11	2019-12-23	Common Shares (500000)	500000	Direct
Stock Options	$0.35	2016-07-11	Common Shares (200000)	700000	Direct
Stock Options	$0.1	2018-06-18	Common Shares (225000)	925000	Direct
Warrants	$0.25	2017-05-15	Common Shares (170000)	170000	Indirect